Review





Similar Products

91
Hycult Biotech anti mouse cd36 antibody
Enhanced lipopolysaccharide (LPS) uptake in LPS‐tolerant RAW264.7 cells is inhibited by treatment with anti‐CD14 antibody. LPS tolerance was induced in RAW264.7 cells by pretreatment with 10 ng mL −1 LPS for 12 h. (A and C) LPS‐tolerant cells were treated with LPS‐Alexa488 in the presence or absence of (A) 2.5 μg mL −1 anti‐CD14 antibody (clone 4C1) and (C) 10 μg mL −1 <t>anti‐CD36</t> antibody. The cells were analyzed using confocal microscopy. LPS‐Alexa488 (green), nuclei stained with DAPI (blue), and merged images with DIC are shown. Scale bars (20 μm) are shown in the top panel; all panels are at the same magnification. (B) LPS‐tolerant or nontolerant cells were treated with LPS‐Alexa488 in the presence of the indicated concentrations of anti‐CD14 antibody (clone 4C1). The fluorescence intensities of the cells analyzed by flow cytometry are shown. For clarity of comparison, the results are separated into four panels for each concentration of anti‐CD14 antibody: 0.63, 1.3, 2.5, and 5.0 μg mL −1 from top to bottom. The same histograms are presented in all panels for direct comparison: nontolerant cells treated with or without LPS‐Alexa488 and LPS‐tolerant cells treated with LPS‐Alexa488. The underlined values in the histograms indicate Geo MFIs. DAPI, 4′,6‐diamidino‐2‐phenylindole; DIC, differential interference contrast.
Anti Mouse Cd36 Antibody, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+cd36/CD36%2C+Mouse%2C+mAb+CRF+D2712/pmc13398632-15-0-9
Average 91 stars, based on 1 article reviews
anti mouse cd36 antibody - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

93
Miltenyi Biotec anti cd36
Enhanced lipopolysaccharide (LPS) uptake in LPS‐tolerant RAW264.7 cells is inhibited by treatment with anti‐CD14 antibody. LPS tolerance was induced in RAW264.7 cells by pretreatment with 10 ng mL −1 LPS for 12 h. (A and C) LPS‐tolerant cells were treated with LPS‐Alexa488 in the presence or absence of (A) 2.5 μg mL −1 anti‐CD14 antibody (clone 4C1) and (C) 10 μg mL −1 <t>anti‐CD36</t> antibody. The cells were analyzed using confocal microscopy. LPS‐Alexa488 (green), nuclei stained with DAPI (blue), and merged images with DIC are shown. Scale bars (20 μm) are shown in the top panel; all panels are at the same magnification. (B) LPS‐tolerant or nontolerant cells were treated with LPS‐Alexa488 in the presence of the indicated concentrations of anti‐CD14 antibody (clone 4C1). The fluorescence intensities of the cells analyzed by flow cytometry are shown. For clarity of comparison, the results are separated into four panels for each concentration of anti‐CD14 antibody: 0.63, 1.3, 2.5, and 5.0 μg mL −1 from top to bottom. The same histograms are presented in all panels for direct comparison: nontolerant cells treated with or without LPS‐Alexa488 and LPS‐tolerant cells treated with LPS‐Alexa488. The underlined values in the histograms indicate Geo MFIs. DAPI, 4′,6‐diamidino‐2‐phenylindole; DIC, differential interference contrast.
Anti Cd36, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+cd36/CD36+Antibody%2C+anti-mouse%2C+REAfinity/pmc13104797-79-28-29
Average 93 stars, based on 1 article reviews
anti cd36 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Bio-Rad cd36
Enhanced lipopolysaccharide (LPS) uptake in LPS‐tolerant RAW264.7 cells is inhibited by treatment with anti‐CD14 antibody. LPS tolerance was induced in RAW264.7 cells by pretreatment with 10 ng mL −1 LPS for 12 h. (A and C) LPS‐tolerant cells were treated with LPS‐Alexa488 in the presence or absence of (A) 2.5 μg mL −1 anti‐CD14 antibody (clone 4C1) and (C) 10 μg mL −1 <t>anti‐CD36</t> antibody. The cells were analyzed using confocal microscopy. LPS‐Alexa488 (green), nuclei stained with DAPI (blue), and merged images with DIC are shown. Scale bars (20 μm) are shown in the top panel; all panels are at the same magnification. (B) LPS‐tolerant or nontolerant cells were treated with LPS‐Alexa488 in the presence of the indicated concentrations of anti‐CD14 antibody (clone 4C1). The fluorescence intensities of the cells analyzed by flow cytometry are shown. For clarity of comparison, the results are separated into four panels for each concentration of anti‐CD14 antibody: 0.63, 1.3, 2.5, and 5.0 μg mL −1 from top to bottom. The same histograms are presented in all panels for direct comparison: nontolerant cells treated with or without LPS‐Alexa488 and LPS‐tolerant cells treated with LPS‐Alexa488. The underlined values in the histograms indicate Geo MFIs. DAPI, 4′,6‐diamidino‐2‐phenylindole; DIC, differential interference contrast.
Cd36, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+cd36/Rat+anti+Mouse+CD36/pm42849443-1194-49-51
Average 93 stars, based on 1 article reviews
cd36 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Miltenyi Biotec anti mouse cd3 viobright b515
Enhanced lipopolysaccharide (LPS) uptake in LPS‐tolerant RAW264.7 cells is inhibited by treatment with anti‐CD14 antibody. LPS tolerance was induced in RAW264.7 cells by pretreatment with 10 ng mL −1 LPS for 12 h. (A and C) LPS‐tolerant cells were treated with LPS‐Alexa488 in the presence or absence of (A) 2.5 μg mL −1 anti‐CD14 antibody (clone 4C1) and (C) 10 μg mL −1 <t>anti‐CD36</t> antibody. The cells were analyzed using confocal microscopy. LPS‐Alexa488 (green), nuclei stained with DAPI (blue), and merged images with DIC are shown. Scale bars (20 μm) are shown in the top panel; all panels are at the same magnification. (B) LPS‐tolerant or nontolerant cells were treated with LPS‐Alexa488 in the presence of the indicated concentrations of anti‐CD14 antibody (clone 4C1). The fluorescence intensities of the cells analyzed by flow cytometry are shown. For clarity of comparison, the results are separated into four panels for each concentration of anti‐CD14 antibody: 0.63, 1.3, 2.5, and 5.0 μg mL −1 from top to bottom. The same histograms are presented in all panels for direct comparison: nontolerant cells treated with or without LPS‐Alexa488 and LPS‐tolerant cells treated with LPS‐Alexa488. The underlined values in the histograms indicate Geo MFIs. DAPI, 4′,6‐diamidino‐2‐phenylindole; DIC, differential interference contrast.
Anti Mouse Cd3 Viobright B515, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+cd36/CD36+Antibody%2C+anti-human/pm41888511-227-34-38
Average 94 stars, based on 1 article reviews
anti mouse cd3 viobright b515 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Miltenyi Biotec pe anti mouse cd36
Enhanced lipopolysaccharide (LPS) uptake in LPS‐tolerant RAW264.7 cells is inhibited by treatment with anti‐CD14 antibody. LPS tolerance was induced in RAW264.7 cells by pretreatment with 10 ng mL −1 LPS for 12 h. (A and C) LPS‐tolerant cells were treated with LPS‐Alexa488 in the presence or absence of (A) 2.5 μg mL −1 anti‐CD14 antibody (clone 4C1) and (C) 10 μg mL −1 <t>anti‐CD36</t> antibody. The cells were analyzed using confocal microscopy. LPS‐Alexa488 (green), nuclei stained with DAPI (blue), and merged images with DIC are shown. Scale bars (20 μm) are shown in the top panel; all panels are at the same magnification. (B) LPS‐tolerant or nontolerant cells were treated with LPS‐Alexa488 in the presence of the indicated concentrations of anti‐CD14 antibody (clone 4C1). The fluorescence intensities of the cells analyzed by flow cytometry are shown. For clarity of comparison, the results are separated into four panels for each concentration of anti‐CD14 antibody: 0.63, 1.3, 2.5, and 5.0 μg mL −1 from top to bottom. The same histograms are presented in all panels for direct comparison: nontolerant cells treated with or without LPS‐Alexa488 and LPS‐tolerant cells treated with LPS‐Alexa488. The underlined values in the histograms indicate Geo MFIs. DAPI, 4′,6‐diamidino‐2‐phenylindole; DIC, differential interference contrast.
Pe Anti Mouse Cd36, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+cd36/CD36+Antibody%2C+anti-mouse%2C+REAfinity/pmc13006431-70-0-6
Average 93 stars, based on 1 article reviews
pe anti mouse cd36 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Miltenyi Biotec anti mouse cd3
Enhanced lipopolysaccharide (LPS) uptake in LPS‐tolerant RAW264.7 cells is inhibited by treatment with anti‐CD14 antibody. LPS tolerance was induced in RAW264.7 cells by pretreatment with 10 ng mL −1 LPS for 12 h. (A and C) LPS‐tolerant cells were treated with LPS‐Alexa488 in the presence or absence of (A) 2.5 μg mL −1 anti‐CD14 antibody (clone 4C1) and (C) 10 μg mL −1 <t>anti‐CD36</t> antibody. The cells were analyzed using confocal microscopy. LPS‐Alexa488 (green), nuclei stained with DAPI (blue), and merged images with DIC are shown. Scale bars (20 μm) are shown in the top panel; all panels are at the same magnification. (B) LPS‐tolerant or nontolerant cells were treated with LPS‐Alexa488 in the presence of the indicated concentrations of anti‐CD14 antibody (clone 4C1). The fluorescence intensities of the cells analyzed by flow cytometry are shown. For clarity of comparison, the results are separated into four panels for each concentration of anti‐CD14 antibody: 0.63, 1.3, 2.5, and 5.0 μg mL −1 from top to bottom. The same histograms are presented in all panels for direct comparison: nontolerant cells treated with or without LPS‐Alexa488 and LPS‐tolerant cells treated with LPS‐Alexa488. The underlined values in the histograms indicate Geo MFIs. DAPI, 4′,6‐diamidino‐2‐phenylindole; DIC, differential interference contrast.
Anti Mouse Cd3, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+cd36/CD36+Antibody%2C+anti-human/10__1016_slash_j__jphs__2026__02__004-82-10-48
Average 94 stars, based on 1 article reviews
anti mouse cd3 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

86
Charles River Laboratories mouse cd36 fl fl
Transcriptomics across muscle depots reveal metabolic shift from glycolytic toward oxidative (A) Experimental set up and color scheme used throughout and . (B) Fold changes of transcripts associated with fatty acid (FA) catabolism and transport as identified in supplementary Extended Data A in muscle of male mice ( n = 6) given ad libitum access to sulfur amino acid-restricted (SAAR) versus control (Con) diet for seven days. (C) Pathway enrichment analysis of genes showing significant diet-by-muscle interaction effects. (D) Fold changes (SAAR vs. Con) of TCA cycle genes in EDL and soleus. (E) Representative blots of electron transport chain complexes. (F) Quantification of relative protein abundance normalized to vinculin of SDHB for EDL and soleus ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. (G) Representative blots of <t>CD36,</t> LPL, and PDK4 and vinculin ( top ) and quantification of relative protein abundance normalized to vinculin of CD36, PDK4, and LPL ( bottom ) in EDL ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. (H) Representative blots of CD36, LPL, and PDK4 and vinculin ( top ) and quantification of relative protein abundance normalized to vinculin of CD36, PDK4, and LPL from blots ( bottom ) in soleus ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. All panels represent data from mice that were not subjected to endurance running. All data are shown as mean, and error bars indicate SD unless otherwise noted; p values indicate the significance of the difference by Student t test between diets; significance is determined by p < 0.05. See also and . Raw data files for E are available in the supplement as ZIP file.
Mouse Cd36 Fl Fl, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+cd36/cd36+loxp+loxp+mice/pmc12721204-58-0-4
Average 86 stars, based on 1 article reviews
mouse cd36 fl fl - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

94
R&D Systems anticd36
Transcriptomics across muscle depots reveal metabolic shift from glycolytic toward oxidative (A) Experimental set up and color scheme used throughout and . (B) Fold changes of transcripts associated with fatty acid (FA) catabolism and transport as identified in supplementary Extended Data A in muscle of male mice ( n = 6) given ad libitum access to sulfur amino acid-restricted (SAAR) versus control (Con) diet for seven days. (C) Pathway enrichment analysis of genes showing significant diet-by-muscle interaction effects. (D) Fold changes (SAAR vs. Con) of TCA cycle genes in EDL and soleus. (E) Representative blots of electron transport chain complexes. (F) Quantification of relative protein abundance normalized to vinculin of SDHB for EDL and soleus ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. (G) Representative blots of <t>CD36,</t> LPL, and PDK4 and vinculin ( top ) and quantification of relative protein abundance normalized to vinculin of CD36, PDK4, and LPL ( bottom ) in EDL ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. (H) Representative blots of CD36, LPL, and PDK4 and vinculin ( top ) and quantification of relative protein abundance normalized to vinculin of CD36, PDK4, and LPL from blots ( bottom ) in soleus ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. All panels represent data from mice that were not subjected to endurance running. All data are shown as mean, and error bars indicate SD unless otherwise noted; p values indicate the significance of the difference by Student t test between diets; significance is determined by p < 0.05. See also and . Raw data files for E are available in the supplement as ZIP file.
Anticd36, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+cd36/Mouse+CD36%2FSR-B3+Antibody/pm41365858-228-96-97
Average 94 stars, based on 1 article reviews
anticd36 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


Enhanced lipopolysaccharide (LPS) uptake in LPS‐tolerant RAW264.7 cells is inhibited by treatment with anti‐CD14 antibody. LPS tolerance was induced in RAW264.7 cells by pretreatment with 10 ng mL −1 LPS for 12 h. (A and C) LPS‐tolerant cells were treated with LPS‐Alexa488 in the presence or absence of (A) 2.5 μg mL −1 anti‐CD14 antibody (clone 4C1) and (C) 10 μg mL −1 anti‐CD36 antibody. The cells were analyzed using confocal microscopy. LPS‐Alexa488 (green), nuclei stained with DAPI (blue), and merged images with DIC are shown. Scale bars (20 μm) are shown in the top panel; all panels are at the same magnification. (B) LPS‐tolerant or nontolerant cells were treated with LPS‐Alexa488 in the presence of the indicated concentrations of anti‐CD14 antibody (clone 4C1). The fluorescence intensities of the cells analyzed by flow cytometry are shown. For clarity of comparison, the results are separated into four panels for each concentration of anti‐CD14 antibody: 0.63, 1.3, 2.5, and 5.0 μg mL −1 from top to bottom. The same histograms are presented in all panels for direct comparison: nontolerant cells treated with or without LPS‐Alexa488 and LPS‐tolerant cells treated with LPS‐Alexa488. The underlined values in the histograms indicate Geo MFIs. DAPI, 4′,6‐diamidino‐2‐phenylindole; DIC, differential interference contrast.

Journal: FEBS Open Bio

Article Title: Lipopolysaccharide uptake is augmented in lipopolysaccharide‐tolerant mouse macrophage‐like cells via increased CD14 expression

doi: 10.1002/2211-5463.70261

Figure Lengend Snippet: Enhanced lipopolysaccharide (LPS) uptake in LPS‐tolerant RAW264.7 cells is inhibited by treatment with anti‐CD14 antibody. LPS tolerance was induced in RAW264.7 cells by pretreatment with 10 ng mL −1 LPS for 12 h. (A and C) LPS‐tolerant cells were treated with LPS‐Alexa488 in the presence or absence of (A) 2.5 μg mL −1 anti‐CD14 antibody (clone 4C1) and (C) 10 μg mL −1 anti‐CD36 antibody. The cells were analyzed using confocal microscopy. LPS‐Alexa488 (green), nuclei stained with DAPI (blue), and merged images with DIC are shown. Scale bars (20 μm) are shown in the top panel; all panels are at the same magnification. (B) LPS‐tolerant or nontolerant cells were treated with LPS‐Alexa488 in the presence of the indicated concentrations of anti‐CD14 antibody (clone 4C1). The fluorescence intensities of the cells analyzed by flow cytometry are shown. For clarity of comparison, the results are separated into four panels for each concentration of anti‐CD14 antibody: 0.63, 1.3, 2.5, and 5.0 μg mL −1 from top to bottom. The same histograms are presented in all panels for direct comparison: nontolerant cells treated with or without LPS‐Alexa488 and LPS‐tolerant cells treated with LPS‐Alexa488. The underlined values in the histograms indicate Geo MFIs. DAPI, 4′,6‐diamidino‐2‐phenylindole; DIC, differential interference contrast.

Article Snippet: Anti‐mouse CD36 antibody (clone CRF D‐2712) was purchased from Hycult Biotech (Uden, Netherlands).

Techniques: Confocal Microscopy, Staining, Fluorescence, Flow Cytometry, Comparison, Concentration Assay

Transcriptomics across muscle depots reveal metabolic shift from glycolytic toward oxidative (A) Experimental set up and color scheme used throughout and . (B) Fold changes of transcripts associated with fatty acid (FA) catabolism and transport as identified in supplementary Extended Data A in muscle of male mice ( n = 6) given ad libitum access to sulfur amino acid-restricted (SAAR) versus control (Con) diet for seven days. (C) Pathway enrichment analysis of genes showing significant diet-by-muscle interaction effects. (D) Fold changes (SAAR vs. Con) of TCA cycle genes in EDL and soleus. (E) Representative blots of electron transport chain complexes. (F) Quantification of relative protein abundance normalized to vinculin of SDHB for EDL and soleus ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. (G) Representative blots of CD36, LPL, and PDK4 and vinculin ( top ) and quantification of relative protein abundance normalized to vinculin of CD36, PDK4, and LPL ( bottom ) in EDL ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. (H) Representative blots of CD36, LPL, and PDK4 and vinculin ( top ) and quantification of relative protein abundance normalized to vinculin of CD36, PDK4, and LPL from blots ( bottom ) in soleus ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. All panels represent data from mice that were not subjected to endurance running. All data are shown as mean, and error bars indicate SD unless otherwise noted; p values indicate the significance of the difference by Student t test between diets; significance is determined by p < 0.05. See also and . Raw data files for E are available in the supplement as ZIP file.

Journal: iScience

Article Title: Angiogenesis-independent VEGF signaling enhances exercise capacity by increasing fat oxidation in mice fed sulfur amino acid-restricted diets

doi: 10.1016/j.isci.2025.114148

Figure Lengend Snippet: Transcriptomics across muscle depots reveal metabolic shift from glycolytic toward oxidative (A) Experimental set up and color scheme used throughout and . (B) Fold changes of transcripts associated with fatty acid (FA) catabolism and transport as identified in supplementary Extended Data A in muscle of male mice ( n = 6) given ad libitum access to sulfur amino acid-restricted (SAAR) versus control (Con) diet for seven days. (C) Pathway enrichment analysis of genes showing significant diet-by-muscle interaction effects. (D) Fold changes (SAAR vs. Con) of TCA cycle genes in EDL and soleus. (E) Representative blots of electron transport chain complexes. (F) Quantification of relative protein abundance normalized to vinculin of SDHB for EDL and soleus ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. (G) Representative blots of CD36, LPL, and PDK4 and vinculin ( top ) and quantification of relative protein abundance normalized to vinculin of CD36, PDK4, and LPL ( bottom ) in EDL ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. (H) Representative blots of CD36, LPL, and PDK4 and vinculin ( top ) and quantification of relative protein abundance normalized to vinculin of CD36, PDK4, and LPL from blots ( bottom ) in soleus ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. All panels represent data from mice that were not subjected to endurance running. All data are shown as mean, and error bars indicate SD unless otherwise noted; p values indicate the significance of the difference by Student t test between diets; significance is determined by p < 0.05. See also and . Raw data files for E are available in the supplement as ZIP file.

Article Snippet: Mouse: CD36 fl/fl , Charles River Laboratories , N/A.

Techniques: Control, Quantitative Proteomics

SAAR increases muscle lipid flux without altering lipid pool sizes (A) Experimental design and color scheme used in A–3E and A. (B) Circulatory carbon flux ( n = 10–13) of 13 C 18 -U-Linolate of jugular-vein-catheterized male mice given ad libitum access to sulfur amino acid-restricted (SAAR) versus control (Con) diet for seven days. (C) Ex vivo β-oxidation measured by incorporation of 3 H-palmitic acid in 3 H-H 2 O in muscles of male mice fed a Con or SAAR diet for seven days ( n = 15). (D) Representative fluorescence images ( left ) of BODIPY 493:503 (green), WGA647 (red), and DAPI (blue) staining in EDL cross sections (scale bar, 50 μm) and quantification of Bodipy + Intensity within fibers ( right ) of male mice fed a Con or SAAR for seven days ( n = 6). (E) Lipidomics analysis from muscle of male mice fed a Con or SAAR diet for seven days ( n = 6), summarized as normalized ion counts of each main lipid class. (F) Experimental set up and color scheme used in G, 3H, and D–S3I. (G) Percent change in body weight ( n = 16) of male WT and EC CD36−/− mice given ad libitum access to SAAR versus Con diet after seven days. (H) Distance ran during a one-time maximal endurance test (n = 9–15) of male WT and EC CD36−/− mice given ad libitum access to SAAR versus Con diet on day seven. B–E represent data from mice that were not subjected to endurance running, G and H represent data from mice subjected to maximal endurance testing. All data are shown as mean, and error bars indicate SD unless otherwise noted; p values indicate the significance of the difference by Student t test between diets, or two-way ANOVA with Sidak multiple comparisons test between diets and muscle or genotype; significance is determined by p < 0.05. See also and , , and .

Journal: iScience

Article Title: Angiogenesis-independent VEGF signaling enhances exercise capacity by increasing fat oxidation in mice fed sulfur amino acid-restricted diets

doi: 10.1016/j.isci.2025.114148

Figure Lengend Snippet: SAAR increases muscle lipid flux without altering lipid pool sizes (A) Experimental design and color scheme used in A–3E and A. (B) Circulatory carbon flux ( n = 10–13) of 13 C 18 -U-Linolate of jugular-vein-catheterized male mice given ad libitum access to sulfur amino acid-restricted (SAAR) versus control (Con) diet for seven days. (C) Ex vivo β-oxidation measured by incorporation of 3 H-palmitic acid in 3 H-H 2 O in muscles of male mice fed a Con or SAAR diet for seven days ( n = 15). (D) Representative fluorescence images ( left ) of BODIPY 493:503 (green), WGA647 (red), and DAPI (blue) staining in EDL cross sections (scale bar, 50 μm) and quantification of Bodipy + Intensity within fibers ( right ) of male mice fed a Con or SAAR for seven days ( n = 6). (E) Lipidomics analysis from muscle of male mice fed a Con or SAAR diet for seven days ( n = 6), summarized as normalized ion counts of each main lipid class. (F) Experimental set up and color scheme used in G, 3H, and D–S3I. (G) Percent change in body weight ( n = 16) of male WT and EC CD36−/− mice given ad libitum access to SAAR versus Con diet after seven days. (H) Distance ran during a one-time maximal endurance test (n = 9–15) of male WT and EC CD36−/− mice given ad libitum access to SAAR versus Con diet on day seven. B–E represent data from mice that were not subjected to endurance running, G and H represent data from mice subjected to maximal endurance testing. All data are shown as mean, and error bars indicate SD unless otherwise noted; p values indicate the significance of the difference by Student t test between diets, or two-way ANOVA with Sidak multiple comparisons test between diets and muscle or genotype; significance is determined by p < 0.05. See also and , , and .

Article Snippet: Mouse: CD36 fl/fl , Charles River Laboratories , N/A.

Techniques: Control, Ex Vivo, Muscles, Fluorescence, Staining